LDL choelsterol
Showing 51 - 75 of 1,261
Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)
Recruiting
- Hypercholesterolemia
- VXX-401
- Placebo
-
Sydney, New South Wales, Australia
- +2 more
Mar 15, 2023
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
-
Amman, Jordan
- +1 more
Nov 23, 2022
Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Atozet 10/40 mg or 10/80 mg
- Lipitor 40 mg or 80 mg
- (no location specified)
Mar 8, 2023
Homozygous Familial Hypercholesterolemia Trial in Netherlands, South Africa, United States (Demographics, diagnosis type,
Recruiting
- Homozygous Familial Hypercholesterolemia
- Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
-
Philadelphia, Pennsylvania
- +3 more
Sep 28, 2022
Cardiovascular Diseases Trial in Paris (Atorvastatin 40mg Tablet, Placebo comparator)
Completed
- Cardiovascular Diseases
- Atorvastatin 40mg Tablet
- Placebo comparator
-
Paris, France
- +1 more
Jan 17, 2023
Coronary Heart Disease (CHD) Trial in Worldwide (Evolocumab, Placebo)
Active, not recruiting
- Coronary Heart Disease (CHD)
- Evolocumab
- Placebo
-
Athens, Alabama
- +851 more
Dec 19, 2022
Diet-induced Elevations in LDL-C and Progression of
Recruiting
- Hypercholesterolemia
-
Torrance, CaliforniaLundquist Institute for Biomedical Innovation at Harbor UCLA Med
Feb 17, 2023
Different Equations to Accurately Calculate LDL Cholesterol
Active, not recruiting
- Dyslipidemias
- Lipid Disorder
- no intervention, Serum LDL cholesterol calculation
-
Bron, FranceLaboratoire de Biologie Médicale Multi Sites, Centre de Biologie
Oct 24, 2022
SLE Trial (Blood test)
Not yet recruiting
- SLE
- Blood test
- (no location specified)
Jul 27, 2022
Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- NGGT006
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023
Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)
Recruiting
- Atherosclerotic Cardiovascular Disease
-
Little Rock, Arkansas
- +43 more
Jan 20, 2023
Intracranial Atherosclerosis, Acute Ischemic Stroke, ICAS - Intracranial Atherosclerosis Trial in Chiayi City (Alirocumab)
Recruiting
- Intracranial Atherosclerosis
- +2 more
-
Chiayi City, TaiwanYenchu Huang
Nov 29, 2022
Cholesterol Variability, Trained Immunity Trial (Atorvastatin)
Not yet recruiting
- Cholesterol Variability
- Trained Immunity
- (no location specified)
Mar 17, 2023
Hypercholesterolemia, Dyslipidemias Trial in Hamburg (lipodia)
Not yet recruiting
- Hypercholesterolemia
- Dyslipidemias
- lipodia
-
Hamburg, GermanyGAIA AG
Aug 3, 2023
Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe
Not yet recruiting
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed dose combination with ezetimibe
- (no location specified)
Mar 23, 2023
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
Non-alcoholic Steatohepatitis (NASH) Trial in Las Vegas (ECC4703, Placebo)
Recruiting
- Non-alcoholic Steatohepatitis (NASH)
- ECC4703
- Placebo
-
Las Vegas, NevadaEccogene Investigational Site
Sep 20, 2022
Diabetes, Elevated Body Mass Index Trial in Houston (Virtual Culinary Medicine)
Not yet recruiting
- Diabetes
- Elevated Body Mass Index
- Virtual Culinary Medicine
-
Houston, TexasThe University of Texas Health Science Center at Houston
Oct 17, 2023
Cardiometabolic Risk Factors Trial in Travis Air Force Base (Facilitated Vegan Diet, Omnivorous Diet)
Active, not recruiting
- Cardiometabolic Risk Factors
- Facilitated Vegan Diet
- Omnivorous Diet
-
Travis Air Force Base, CaliforniaDavid Grant U.S. Air Force Medical Center
Mar 30, 2022
Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)
Recruiting
- Familial Hypercholesterolemia - Heterozygous
- Inclisiran
- Placebo
-
Tucson, Arizona
- +76 more
Aug 8, 2022
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Dyslipidemias, Hypertension Trial in Georgia, Russian Federation, Ukraine (Atorvastatin/Perindopril, Atorvastatin, Perindopril)
Terminated
- Dyslipidemias
- Hypertension
- Atorvastatin/Perindopril
- +2 more
-
Kutaisi, Georgia
- +41 more
Dec 2, 2022